These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 20225021)

  • 1. Mitochondrial disorders due to nuclear OXPHOS gene defects.
    Ugalde C; Morán M; Blázquez A; Arenas J; Martín MA
    Adv Exp Med Biol; 2009; 652():85-116. PubMed ID: 20225021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic and clinical aspects of mitochondrial disorders in childhood.
    Moslemi AR; Darin N
    Mitochondrion; 2007 Jul; 7(4):241-52. PubMed ID: 17376748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical methods for the diagnosis of mitochondrial diseases.
    De Paepe B; De Bleecker JL; Van Coster R
    Curr Protoc Hum Genet; 2009 Oct; Chapter 19():Unit19.2. PubMed ID: 19806589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome analysis of complex I-deficient patients reveals distinct expression programs for subunits and assembly factors of the oxidative phosphorylation system.
    van der Lee R; Szklarczyk R; Smeitink J; Smeets HJ; Huynen MA; Vogel R
    BMC Genomics; 2015 Sep; 16():691. PubMed ID: 26369791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.
    Hock DH; Robinson DRL; Stroud DA
    Biochem J; 2020 Nov; 477(21):4085-4132. PubMed ID: 33151299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OXPHOS mutations and neurodegeneration.
    Koopman WJ; Distelmaier F; Smeitink JA; Willems PH
    EMBO J; 2013 Jan; 32(1):9-29. PubMed ID: 23149385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transmission of OXPHOS disease and methods to prevent this.
    Jacobs LJ; de Wert G; Geraedts JP; de Coo IF; Smeets HJ
    Hum Reprod Update; 2006; 12(2):119-36. PubMed ID: 16199488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex Deficiencies.
    Gardeitchik T; Mohamed M; Ruzzenente B; Karall D; Guerrero-Castillo S; Dalloyaux D; van den Brand M; van Kraaij S; van Asbeck E; Assouline Z; Rio M; de Lonlay P; Scholl-Buergi S; Wolthuis DFGJ; Hoischen A; Rodenburg RJ; Sperl W; Urban Z; Brandt U; Mayr JA; Wong S; de Brouwer APM; Nijtmans L; Munnich A; Rötig A; Wevers RA; Metodiev MD; Morava E
    Am J Hum Genet; 2018 Apr; 102(4):685-695. PubMed ID: 29576219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronized mitochondrial and cytosolic translation programs.
    Couvillion MT; Soto IC; Shipkovenska G; Churchman LS
    Nature; 2016 May; 533(7604):499-503. PubMed ID: 27225121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders related to mitochondrial membranes: pathology of the respiratory chain and neurodegeneration.
    Di Donato S
    J Inherit Metab Dis; 2000 May; 23(3):247-63. PubMed ID: 10863941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear gene defects in mitochondrial disorders.
    Scaglia F
    Methods Mol Biol; 2012; 837():17-34. PubMed ID: 22215538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oxidative phosphorylation (OXPHOS) system: nuclear genes and human genetic diseases.
    van den Heuvel L; Smeitink J
    Bioessays; 2001 Jun; 23(6):518-25. PubMed ID: 11385631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases.
    Saada A
    Mol Genet Metab; 2011; 104(1-2):39-47. PubMed ID: 21835663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mitochondrial disorders: a classification for the 21st century].
    Andreu AL; Gonzalo-Sanz R
    Neurologia; 2004; 19(1):15-22. PubMed ID: 14762729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical differences in patients with mitochondriocytopathies due to nuclear versus mitochondrial DNA mutations.
    Rubio-Gozalbo ME; Dijkman KP; van den Heuvel LP; Sengers RC; Wendel U; Smeitink JA
    Hum Mutat; 2000; 15(6):522-32. PubMed ID: 10862082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.
    Ugalde C; Janssen RJ; van den Heuvel LP; Smeitink JA; Nijtmans LG
    Hum Mol Genet; 2004 Mar; 13(6):659-67. PubMed ID: 14749350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear genetic defects of oxidative phosphorylation.
    Shoubridge EA
    Hum Mol Genet; 2001 Oct; 10(20):2277-84. PubMed ID: 11673411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of mitochondrial diseases.
    Ylikallio E; Suomalainen A
    Ann Med; 2012 Feb; 44(1):41-59. PubMed ID: 21806499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein synthesis and assembly in mitochondrial disorders.
    Pérez-Martínez X; Funes S; Camacho-Villasana Y; Marjavaara S; Tavares-Carreón F; Shingú-Vázquez M
    Curr Top Med Chem; 2008; 8(15):1335-50. PubMed ID: 18991722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.